584PNoninferiority on overall survival of every-2-weeks vs weekly schedule of cetuximab for first-line treatment of RAS wild-type metastatic colorectal cancer Stefan Kasper-Virchow,Ann-Lll Cheng,Friedrich Overkamp,Magali Rouyer,Caroline Foch,Francois-Xavier Lamy,Regina Esser,Diethelm Messinger,Vivien Rothe,Wenfeng Chen,Thomas Brodowicz,Christoph ZielinskiANNALS OF ONCOLOGY（2019）引用 3|浏览10暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
